The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers
Open accessAbstract
Adenocarcinoma is the most common type of lung cancer, the leading cause of cancer deaths in the world. Early detection is the key to improve the survival of lung adenocarcinoma patients. We have previously shown that microRNAs (miRNAs) were stably present in sputum and could be applied to diagnosis of lung cancer. The aim of our study was to develop a panel of miRNAs that can be used as highly sensitive and specific sputum markers for early detection of lung adenocarcinoma. Our study contained 3 phases: (i) marker discovery using miRNA profiling on paired normal and tumor lung tissues from 20 patients with lung adenocarcinoma; (ii) marker optimization by real‐time reverse transcription‐quantitative polymerase chain reaction on sputum of a case–control cohort consisting of 36 cancer patients and 36 health individuals and (iii) validation on an independent set of 64 lung cancer patients and 58 cancer‐free subjects. From the surgical tissues, 7 miRNAs with significantly altered expression were identified, of which “4” were overexpressed and “3” were underexpressed in all 20 tumors. On the sputum samples of the case–control cohort, 4 (miR‐21, miR‐486, miR‐375 and miR‐200b) of the 7 miRNAs were selected, which in combination produced the best prediction in distinguishing lung adenocarcinoma patients from normal subjects with 80.6% sensitivity and 91.7% specificity. Validation of the marker panel in the independent populations confirmed the sensitivity and specificity that provided a significant improvement over any single one alone. The sputum markers demonstrated the potential of translation to laboratory settings for improving the early detection of lung adenocarcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,798
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023
Pathology and genetics of tumours of the lung , pleura, thymus and heart
Travis, W. D. (2004) · Cited by 1,955
Lung cancer in never smokers — a different disease
Sun, S., Schiller, J. H., & Gazdar, A. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2190 · Cited by 1,608
Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models
Zou, K. H., O’Malley, A. J., & Mauri, L. (2007) · Circulation · doi:10.1161/circulationaha.105.594929 · Cited by 1,473
MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)
Zhu, S., Si, M.-L., Wu, H., & Mo, Y.-Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611393200 · Cited by 1,090
Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells
Guttilla, I. K., & White, B. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.031427 · Cited by 560
Minna, J. D., Roth, J. A., & Gazdar, A. F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00027-2 · Cited by 549
Segura, M. F., Hanniford, D., Menendez, S., Reavie, L., Zou, X., Alvarez-Diaz, S., Zakrzewski, J., Blochin, E., Rose, A., Bogunovic, D., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808263106 · Cited by 542
Lebanony, D., Benjamin, H., Gilad, S., Ezagouri, M., Dov, A., Ashkenazi, K., Gefen, N., Izraeli, S., Rechavi, G., Pass, H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.4134 · Cited by 408
Detection of oncogene mutations in sputum precedes diagnosis of lung cancer
(1994) · Lung Cancer · doi:10.1016/0169-5002(94)92208-x · Cited by 398
Belinsky, S. A., Liechty, K. C., Gentry, F. D., Wolf, H. J., Rogers, J., Vu, K., Haney, J., Kennedy, T. C., Hirsch, F. R., Miller, Y., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3408 · Cited by 389
Mathé, E. A., Nguyen, G. H., Bowman, E. D., Zhao, Y., Budhu, A., Schetter, A. J., Braun, R., Reimers, M., Kumamoto, K., Hughes, D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1467 · Cited by 374
Partial AUC Estimation and Regression
Dodd, L. E., & Pepe, M. S. (2003) · Biometrics · doi:10.1111/1541-0420.00071 · Cited by 346
SAMPLE SIZE DETERMINATION FOR DIAGNOSTIC ACCURACY STUDIES INVOLVING BINORMAL ROC CURVE INDICES
OBUCHOWSKI, N. A., & McCLISH, D. K. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970715)16:13<1529::aid-sim565>3.0.co;2-h · Cited by 332
Myatt, S. S., Wang, J., Monteiro, L. J., Christian, M., Ho, K.-K., Fusi, L., Dina, R. E., Brosens, J. J., Ghaem-Maghami, S., & Lam, E. W.-F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1891 · Cited by 318
Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer
Xie, Y., Todd, N. W., Liu, Z., Zhan, M., Fang, H., Peng, H., Alattar, M., Deepak, J., Stass, S. A., & Jiang, F. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.04.004 · Cited by 316
Self-citationFlehinger, B. J., Melamed, M. R., Zaman, M., Heelan, R. T., Perchick, W. B., & Martini, N. (1984) · PubMed · doi:10.1164/arrd.1984.130.4.555 · Cited by 266
Patnaik, S. K., Kannisto, E., Knudsen, S., & Yendamuri, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3153 · Cited by 248
A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer
Nagaraja, A. K., Creighton, C. J., Yu, Z., Zhu, H., Gunaratne, P. H., Reid, J. G., Olokpa, E., Itamochi, H., Ueno, N. T., Hawkins, S. M., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0295 · Cited by 230
Navon, R., Wang, H., Steinfeld, I., Tsalenko, A., Ben-Dor, A., & Yakhini, Z. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008003 · Cited by 165
MicroRNA expression in head and neck cancer associates with alcohol consumption and survival
Avissar-Whiting, M., McClean, M. D., Kelsey, K. T., & Marsit, C. J. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp277 · Cited by 158
Li, R., Wang, H., Bekele, B. N., Yin, Z., Caraway, N. P., Katz, R. L., Stass, S. A., & Jiang, F. (2005) · Oncogene · doi:10.1038/sj.onc.1209289 · Cited by 131
Self-citationPdcd4, a colon cancer prognostic that is regulated by a microRNA.
Allgayer, H. (2007) · Critical reviews in oncology/hematology · doi:10.1016/j.critrevonc.2009.09.001 · Cited by 125
Sputum examination for early detection of lung cancer: Table 1
Thunnissen, E. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.11.805 · Cited by 125
Sahai, H., & Khurshid, A. (1996) · Statistics in Medicine · Cited by 118
Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy
Wang, Q. Z., Xu, W., Habib, N., & Xu, R. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788486731 · Cited by 111
Differential Expression of PTEN-Targeting MicroRNAs miR-19a and miR-21 in Cowden Syndrome
Pezzolesi, M. G., Platzer, P., Waite, K. A., & Eng, C. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.04.005 · Cited by 101
Li, R., Todd, N. W., Qiu, Q., Fan, T., Zhao, Y., Rodgers, W. H., Fang, H.-B., Katz, R. L., Stass, S. A., & Jiang, F. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1593 · Cited by 98
Self-citationJiang, F., Yin, Z., Caraway, N. P., Li, R., & Katz, R. L. (2004) · Neoplasia · doi:10.1593/neo.04142 · Cited by 92
Self-citationYakubovskaya, M. S., Spiegelman, V. S., Luo, F., Sg, M., Salnev, A., Zborovskaya, I. B., Gasparyan, A., Polotsky, B. E., Мачаладзе, З. О., Ac, T., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630611 · Cited by 83
Jeon, J., Shim, S.-M., Nam, H., Baik, S.-Y., Kim, J., & Han, B. (2007) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2006.10.010 · Cited by 49
Magnetic enrichment of bronchial epithelial cells from sputum for lung cancer diagnosis
Qiu, Q., Todd, N. W., Li, R., Peng, H. Q., Liu, Z., Yfantis, H. G., Katz, R. L., Stass, S. A., & Jiang, F. (2008) · Cancer · doi:10.1002/cncr.23596 · Cited by 44
Self-citationAraki, K., Hino, O., Miyazaki, J., & Yamamura, K. (1991) · Carcinogenesis · doi:10.1093/carcin/12.11.2059 · Cited by 15
Tumors Produced by Estradiol Benzoate in the Guinea Pig
Woodruff, L. M. (1941) · Cancer Research · Cited by 2
Cited by
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Iorio, M. V., & Croce, C. M. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100209 · Cited by 1,739
Progress and prospects of early detection in lung cancer
Blandin Knight, S., Crosbie, P. A., Balata, H., Chudziak, J., Hussell, T., & Dive, C. (2017) · Open Biology · doi:10.1098/rsob.170070 · Cited by 935
Alberg, A. J., Brock, M. V., Ford, J. G., Samet, J. M., & Spivack, S. D. (2013) · Chest · doi:10.1378/chest.12-2345 · Cited by 737
Regulation and function of miRNA-21 in health and disease
Kumarswamy, R., Volkmann, I., & Thum, T. (2011) · RNA Biology · doi:10.4161/rna.8.5.16154 · Cited by 607
MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance
Iqbal, M. A., Arora, S., Prakasam, G., Calin, G. A., & Syed, M. A. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.003 · Cited by 449
Metadata
- Authors
- Yu, L., Todd, N. W., Xing, L., Xie, Y., Zhang, H., Liu, Z., Fang, H., Zhang, J., Katz, R. L., & Jiang, F.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2010-03-02
- Volume
- 127
- Issue
- 12
- Pages
- 2870-2878
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1996745846
- Cited by
- 353
- References
- 37
- FWCI
- 10.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.